Skip to main content
. Author manuscript; available in PMC: 2019 Aug 1.
Published in final edited form as: Int J Cancer. 2018 Mar 30;143(3):552–560. doi: 10.1002/ijc.31350

Table 4.

Analysis of CIN Regression Imprinted Gene DMRs among CIN1 cases in North Carolina: Stratified by Age at Enrollment*

Gene CpG Site Overall Age <25 years
N=56
Age ≥25 years
N=78

HR (95% CI)
IGFAS 5 0.41 (0.23, 0.76) 0.41 (0.17, 0.97) 0.65 (0.34, 1.25)
Kv DMR§ 0.83 (0.55, 1.26) 0.73 (0.40, 1.34) 0.86 (0.52, 1.41)
MEG3 DMR§ 0.89 (0.57, 1.38) 1.53 (0.80, 2.94) 0.54 (0.32, 0.92)
PEG10 DMR§ 0.80 (0.65, 0.98) 0.60 (0.43, 0.85) 0.88 (0.69, 1.12)
*

CIN = cervical intraepithelial neoplasia; 151 cases with at least one follow-up visit

HR=Hazard ratio; 95% CI= 95% confidence intervals; continuous methylation levels rescaled using interquartile range for each CpG site

Adjusted for race, current smoking, continuous parity and history of oral contraceptive use

§

DMR = differentially methylated region (median of all CpG sites

MEG3 intronic differentially methylated region